ArticleVaccines2024

Pfizer-BioNTech (BNT162b2) Vaccine Effectiveness against Symptomatic Laboratory-Confirmed COVID-19 Infection among Outpatients in Sentinel Sites, Lebanon, July-December 2021.

Lina Chaito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.